Biotechnology companies play a vital role in advancing medical innovations and therapies, including breakthroughs and the development of novel therapies for various diseases.
The PRISM Emerging Biotech Index tracks small and micro-cap stocks that are contributing to healthcare innovation and economic growth.
| PRISM Emerging Biotech IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| 3.2% | $133.20 | 33.2% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| Equillium, Inc. | EQ | $0.63 | -2.292% | 137 | 177 | $22 | $0.73 | -14.1% |
| NeuroBo Pharmaceuticals, Inc. | NRBO | $2.36 | 0.426% | 13 | 43 | $20 | $4.11 | -42.6% |
| Immuron Limited | IMRN | $2.01 | 6.349% | 2 | 8 | $11 | $1.90 | 5.8% |
| Creative Medical Technology Holdings, Inc. | CELZ | $2.32 | 9.953% | 59 | 42 | $4 | $4.60 | -49.6% |
| Kamada Ltd. | KMDA | $6.03 | -0.331% | 23 | 37 | $347 | $6.16 | -2.1% |
| Achilles Therapeutics plc | ACHL | $1.15 | 0.877% | 280 | 157 | $47 | $0.87 | 31.9% |
| Adverum Biotechnologies, Inc. | ADVM | $5.02 | 5.907% | 314 | 232 | $104 | $0.83 | 506.2% |
| iBio, Inc. | IBIO | $2.41 | -0.219% | 73 | 147 | $22 | $1.38 | 74.6% |
| AIM ImmunoTech Inc. | AIM | $0.20 | 3.077% | 271 | 447 | $13 | $0.48 | -57.7% |
| Palisade Bio, Inc. | PALI | $1.77 | 3.509% | 121 | 1,277 | $5 | $0.58 | 205.8% |
| BioLineRx Ltd. | BLRX | $0.22 | -3.985% | 2,139 | 1,046 | $24 | $1.53 | -85.4% |
| Immatics N.V. | IMTX | $7.06 | -0.563% | 346 | 632 | $843 | $10.72 | -34.1% |
| Vaxart, Inc. | VXRT | $0.61 | -0.131% | 1,700 | 1,309 | $138 | $0.61 | -0.2% |
| Capricor Therapeutics, Inc. | CAPR | $14.08 | 0.5% | 669 | 2,478 | $640 | $5.12 | 175.0% |
| Lisata Therapeutics, Inc. | LSTA | $3.13 | 2.288% | 7 | 16 | $26 | $2.78 | 12.6% |
| Quince Therapeutics, Inc. | QNCX | $1.75 | 2.339% | 195 | 584 | $77 | $1.04 | 68.3% |
| NeuroSense Therapeutics Ltd. | NRSN | $1.27 | -0.781% | 434 | 277 | $29 | $0.80 | 58.8% |
| Addex Therapeutics Ltd | ADXN | $7.81 | -1.139% | 22 | 41 | $12 | $6.30 | 24.0% |
| ZyVersa Therapeutics, Inc. | ZVSA | $1.23 | 6.957% | 60 | 1,303 | $3 | $0.88 | 39.8% |
| Metagenomi, Inc. Common Stock | MGX | $4.03 | 6.897% | 1,006 | 1,822 | $151 | $10.31 | -60.9% |
| 180 Life Sciences Corp. | ATNF | $2.83 | -2.414% | 776 | 2,332 | $6 | $3.91 | -27.6% |
| OS Therapies Incorporated | OSTX | $5.11 | 33.29% | 109 | 57 | $108 | $4.41 | 15.8% |
| Klotho Neuroscience Inc. | KLTO | $0.46 | -0.668% | 113 | 530 | $10 | $1.73 | -73.4% |
| Annexon, Inc. | ANNX | $5.26 | 0.574% | 529 | 1,384 | $561 | $4.84 | 8.7% |
| Poseida Therapeutics, Inc. | PSTX | $9.51 | 0.211% | 647 | 1,250 | $927 | $3.38 | 181.4% |
| Rezolute, Inc. | RZLT | $5.01 | 13.606% | 472 | 379 | $290 | $1.02 | 393.6% |
| Foghorn Therapeutics Inc. | FHTX | $5.09 | 1.394% | 128 | 152 | $283 | $8.45 | -39.8% |
| Innate Pharma S.A. | IPHA | $2.11 | 2.427% | 42 | 483 | $175 | $5.72 | -63.1% |
| Chemomab Therapeutics Ltd. | CMMB | $1.99 | 16.374% | 175 | 119 | $38 | $0.54 | 270.0% |
| Plus Therapeutics, Inc. | PSTV | $1.08 | 0% | 29 | 92 | $6 | $1.85 | -41.6% |
| Ardelyx, Inc. | ARDX | $4.81 | 3.664% | 4,419 | 4,321 | $1,139 | $6.05 | -20.5% |
| Eupraxia Pharmaceuticals Inc. | EPRX | $3.18 | 2.251% | 12 | 17 | $113 | $4.16 | -23.6% |
| Taysha Gene Therapies, Inc. | TSHA | $1.86 | 0.541% | 1,052 | 4,377 | $381 | $1.71 | 8.8% |
| Oragenics, Inc. | OGEN | $0.39 | 3.704% | 378 | 808 | $5 | $6.78 | -94.2% |
| Entrada Therapeutics, Inc. | TRDA | $17.74 | 1.025% | 46 | 129 | $664 | $15.17 | 16.9% |
| Akebia Therapeutics, Inc. | AKBA | $1.93 | 3.763% | 1,650 | 2,044 | $421 | $1.27 | 52.0% |
| Enliven Therapeutics, Inc. | ELVN | $22.71 | -1.901% | 134 | 260 | $1,110 | $14.90 | 52.4% |
| TG Therapeutics, Inc. | TGTX | $33.50 | 4.167% | 1,264 | 2,931 | $5,215 | $17.04 | 96.6% |
| Myriad Genetics, Inc. | MYGN | $13.50 | -1.747% | 596 | 923 | $1,229 | $19.00 | -28.9% |
| Coya Therapeutics, Inc. | COYA | $5.47 | 2.052% | 49 | 94 | $91 | $6.96 | -21.4% |
| Ocular Therapeutix, Inc. | OCUL | $8.54 | 2.521% | 515 | 1,059 | $1,343 | $4.81 | 77.5% |
| Enlivex Therapeutics Ltd. | ENLV | $1.25 | 1.626% | 101 | 239 | $27 | $3.30 | -62.1% |
| Actuate Therapeutics Inc | ACTU | $8.40 | 11.554% | 79 | 58 | $164 | $8.61 | -2.4% |
| Cardiol Therapeutics Inc. | CRDL | $1.32 | 4.762% | 472 | 489 | $108 | $0.88 | 50.0% |
| Shattuck Labs, Inc. | STTK | $1.11 | 0% | 114 | 681 | $53 | $7.56 | -85.3% |
